← Analysis page  ·  Pieter Slegers hub  ·  Research hub

Actionable insights — The Next Berkshire Hathaway

Reading a teaser: separating the thesis from the sales copy, identifying a withheld name from its own disclosures, and checking a borrowed authority before you accept the framework attached to it.
2026-JUL-15 · Compounding Quality (Substack, promotional issue) · Pieter Slegers · read ↗ · full analysis · transcript
How to read this page: a marketing issue, so most of the methods are about reading rather than investing — how to extract the checkable content from a teaser, how to identify a withheld company, and which claims to discount. The one genuine investing insight is the size argument, and the last two entries are cautions. Written post, so no timestamps.

1. Identify a withheld company from the facts the teaser must disclose to be persuasive

The repeatable method
  1. List every specific, checkable claim the piece makes — returns, multiples, share counts, assets, biography.
  2. Prefer structural facts over adjectives: a named asset or an exact share-count change identifies a company; "world-class management" does not.
  3. Cross-reference two or three independent facts. One can coincide; three cannot.
  4. Then verify against a source outside the teaser, and treat the identification as provisional until you do.
  5. Note what the teaser deliberately leaves out — that gap is usually where the weakness is.
Here: the disclosures are enough on their own — a founder who "at just 35 years old… took a struggling trucking insurer," ownership of "one of the largest airports in India," insurers "across the US, Middle East and Europe," a share count cut "from 27 million to 20 million," 8x earnings, and a 34.2% five-year return. The archive confirms it four weeks later by buying Fairfax Financial with the identical framing. What is left out of both: any fair value.
Watch for

2. Separate the thesis from the sales copy, and grade them separately

The repeatable method
  1. Split the piece into two columns: verifiable claims about the business, and claims about the offer or the author.
  2. Score only the first column. The second tells you about incentives, not about the investment.
  3. Check the first column for internal consistency; a number that contradicts itself in the same piece was not checked.
  4. Ask whether the same case, written without a subscription attached, would use the same emphasis.
Here: the thesis column is genuinely substantive — 34.2% a year over five years, 8x earnings, 30x smaller than Berkshire, a 26% share-count reduction, insider buying. The copy column contains the tells: the market is "$50 trillion" in one paragraph and "a $3.9 trillion market" in another; ages are given as 94/28 against 95/29 four weeks earlier; and the closing offer promotes an entirely different report about biotechnology.
Watch for

3. Underwrite the runway, not the record

The repeatable method
  1. Ask what size the company was when it produced its historical return, and what size it is now.
  2. Convert the target growth into absolute money required each year at today's base.
  3. Judge whether the markets it operates in are large enough to absorb that amount.
  4. Discount the historical rate by the change in scale — a compounder that is ten times bigger does not repeat its own record.
Here: the argument is made explicitly and in the right direction. "$5,000 [in Berkshire] in 1985 would be worth more than $8 million today. The problem? Berkshire is now simply too large to repeat those extraordinary returns." The candidate is "about 30x smaller… That means it still has a long runway for growth," with management targeting a doubling every five years (about 15% a year) — notably less than the 34.2% just cited.
Watch for

4. Check a borrowed authority before you accept the framework attached to it

The repeatable method
  1. When a checklist is attributed to a named book or author, verify that the book actually contains it.
  2. Ask whether the framework is being lent credibility it did not earn.
  3. Judge the checklist on its own merits — it may be good and still be misattributed.
  4. Treat a misattribution as a signal about the care taken elsewhere in the piece.
Here: "In his book The Outsiders, Will Thorndike found that the best capital allocators in history shared 7 key characteristics: strong competitive moat, high profitability, low capital requirements, excellent capital allocation, high management integrity, strong long-term growth, powerful secular tailwinds." That is this archive's own quality list, restated verbatim in the 16 June letter. Thorndike's book studies eight CEOs and their capital-allocation decisions; it is not a list of business-quality criteria.
Watch for

5. Record where an idea came from, and treat network ideas differently from screen ideas

The repeatable method
  1. Log the provenance of every idea: a screen, a filing, a conversation, a competitor's holding.
  2. Ideas from people carry information the screen cannot see — and also carry the risk that you are borrowing conviction rather than building it.
  3. Apply the same analytical standard regardless of source; the provenance decides how you found it, not how you underwrite it.
  4. Track the hit rate by source over time. It is the cheapest process improvement available.
Here: "Earlier this year, I sat down with Lauren Templeton in Omaha… That day in Omaha, she told me about 'The Next Berkshire Hathaway'." Compare the origin of everything else in this archive — the monthly Buy list, built from a screen — and note that the Omaha trip is repeatedly described as a source of relationships rather than of information.
Watch for

6. Hold a teaser to the publisher's own evidentiary standard

The repeatable method
  1. Establish what the publisher normally provides before recommending something — for this archive, a fair value, a forward multiple against history, and a reverse DCF.
  2. Check whether the promotional piece meets that standard.
  3. Where it does not, note what is substituted: a track record, an analogy, a management target, an insider purchase.
  4. Decide whether the substitution is justified by the business type or whether the standard simply slipped for the sales issue.
Here: six days after publishing a rating sheet with a fair value, a forward PE against a five-year average and a reverse DCF for every one of 54 names — in which this same company shows only a 7.9% discount and a multiple 13.8% above its own average — this letter presents it as a company that could "5x from here" on the strength of a record, an analogy and a buyback. Both are the archive's own output, six days apart.
Watch for

Methods distilled from the archived Compounding Quality post for personal study. Not investment advice.